PTC Therapeutics Aktie
43,80
EUR
+0,20
EUR
+0,46
%
45,82
USD
-0,36
USD
-0,78
%
Werbung
PTC Therapeutics Aktie Analyse
| 01.10.18 | PTC Therapeutics Overweight | Cantor Fitzgerald | |
| 04.04.18 | PTC Therapeutics Underweight | Barclays Capital | |
| 29.01.18 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 29.09.17 | PTC Therapeutics Equal weight | Barclays Capital | |
| 29.09.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 16.03.17 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 03.03.17 | PTC Therapeutics Equal weight | Barclays Capital | |
| 11.11.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
|
Werbung
|
|||
| 01.03.16 | PTC Therapeutics overweight | Barclays Capital | |
| 01.03.16 | PTC Therapeutics Neutral | Wedbush Morgan Securities Inc. | |
| 01.03.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 24.02.16 | PTC Therapeutics Outperform | Wedbush Morgan Securities Inc. | |
| 24.02.16 | PTC Therapeutics Sector Perform | RBC Capital Markets | |
| 16.10.15 | PTC Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 16.10.15 | PTC Therapeutics Outperform | RBC Capital Markets | |
| 31.07.15 | PTC Therapeutics Outperform | RBC Capital Markets | |
| 05.05.15 | PTC Therapeutics Neutral | ROTH Capital Partners, LLC | |
| 23.04.15 | PTC Therapeutics Outperform | Oppenheimer & Co. Inc. | |
| 09.04.15 | PTC Therapeutics Buy | Deutsche Bank AG | |
| 04.03.15 | PTC Therapeutics overweight | Barclays Capital | |
| 02.03.15 | PTC Therapeutics Buy | ROTH Capital Partners, LLC | |
| 23.01.15 | PTC Therapeutics Outperform | RBC Capital Markets | |
| 29.09.14 | PTC Therapeutics Buy | ROTH Capital Partners, LLC | |
Werbung
Werbung